Chugai Pharmaceutical Co., Ltd.
CHGCF
$47.72
$1.312.82%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 833.22M | -673.22M | 638.03M | 600.37M | -- |
| Total Depreciation and Amortization | 203.97M | -2.77M | -- | 199.76M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -996.17M | -245.97M | -467.94M | -874.68M | -276.26M |
| Change in Net Operating Assets | 796.72M | 1.75B | 267.43M | 1.07B | 956.07M |
| Cash from Operations | 837.74M | 826.74M | 437.52M | 999.28M | 679.81M |
| Capital Expenditure | -112.72M | -185.72M | -145.02M | 1.27M | -83.38M |
| Sale of Property, Plant, and Equipment | 1.45M | 50.94M | -- | -3.34M | -640.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -938.12M | -187.74M | -425.11M | -108.76M | -133.20M |
| Cash from Investing | -1.05B | -322.53M | -570.13M | -110.84M | -217.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 5.93B | 2.03B | -2.03B | 6.09B | -- |
| Issuance of Common Stock | 12.00M | 11.00M | 115.00M | 16.00M | 75.00M |
| Repurchase of Common Stock | -3.00M | -1.00M | -1.00M | -1.00M | -3.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -3.03M | -612.93M | -1.90M | -437.61M |
| Other Financing Activities | -8.32B | -4.07B | -51.00M | -7.85B | -1.98B |
| Cash from Financing | -14.63M | -17.07M | -625.85M | -13.32M | -450.49M |
| Foreign Exchange rate Adjustments | 32.71M | 22.92M | -7.85M | 18.26M | 16.11M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -6.60K | 6.70K |
| Net Change in Cash | -193.56M | 510.06M | -766.31M | 893.38M | 28.22M |